What is Irritable Bowel Syndrome (IBS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Understanding Irritable Bowel Syndrome (IBS)

Irritable Bowel Syndrome (IBS) is a chronic functional gastrointestinal disorder characterized by recurrent abdominal pain associated with altered bowel habits that cannot be explained by structural or biochemical abnormalities. 1

Definition and Diagnostic Criteria

IBS is diagnosed using the Rome III criteria, which require:

  • Recurrent abdominal pain or discomfort for at least 3 days per month in the last 3 months, associated with two or more of the following:
    • Improvement with defecation
    • Onset associated with change in stool frequency
    • Onset associated with change in stool form/appearance 1

These symptoms should be present for at least 6 months prior to diagnosis to be considered chronic.

Epidemiology

IBS is extremely common worldwide:

  • Prevalence ranges from 2.5% to 25% depending on the criteria used and population studied
  • More common in women than men
  • Typically affects people under 50 years of age
  • Prevalence varies by country (e.g., 14.1% in USA, 6.6% in Hong Kong, 8.5% in Italy) 1

IBS Subtypes

Based on predominant stool consistency, IBS is classified into:

  1. IBS with constipation (IBS-C): Hard stools >25% of the time and loose stools <25% of the time
  2. IBS with diarrhea (IBS-D): Loose stools >25% of the time and hard stools <25% of the time
  3. IBS with mixed bowel habits (IBS-M): Both hard and soft stools >25% of the time
  4. Unclassified IBS (IBS-U): Neither loose nor hard stools >25% of the time 1

Some patients switch between subtypes over time and are termed "alternators."

Clinical Features

Key Symptoms

  • Abdominal pain: Central feature, often relieved by defecation
  • Altered bowel habits: Constipation, diarrhea, or alternating patterns
  • Bloating: Common and often distressing
  • Additional symptoms:
    • Mucus in stool
    • Feeling of incomplete evacuation
    • Urgency
    • Straining during defecation 1

Symptom Patterns

  • Most patients experience intermittent symptoms with flares lasting 2-4 days followed by remission
  • Morning symptoms are common, with repeated defecation and progressive loosening of stool
  • Symptoms often worsen after meals and during periods of stress 1

Pathophysiology

Multiple mechanisms contribute to IBS development:

  1. Brain-gut axis dysregulation: Altered communication between central nervous system and enteric nervous system 1
  2. Visceral hypersensitivity: Increased pain perception to normal gut stimuli 1, 2
  3. Altered gut motility: Abnormal contractions affecting transit time 1
  4. Low-grade inflammation: Particularly in post-infectious IBS 3
  5. Altered gut microbiota: Dysbiosis may contribute to symptoms 4
  6. Psychological factors: Stress, anxiety, and depression can trigger or worsen symptoms 1

Diagnosis

Diagnosis is based on:

  1. Positive symptom criteria (Rome III criteria)

  2. Absence of alarm features:

    • Age >50 years
    • Weight loss
    • Rectal bleeding
    • Nocturnal symptoms
    • Family history of colon cancer
    • Anemia 1
  3. Helpful diagnostic behavioral features:

    • Symptoms present >6 months
    • Frequent consultations for non-GI symptoms
    • Previous medically unexplained symptoms
    • Patient reports stress aggravates symptoms 1

Limited investigations are needed in typical cases without alarm features.

Management Approach

Management requires a multidisciplinary approach addressing:

1. Medical Management

  • Antispasmodics: For pain and cramping
  • Laxatives: For constipation-predominant IBS
  • Antidiarrheals: For diarrhea-predominant IBS
  • 5-HT3 receptor antagonists (e.g., alosetron): For IBS-D, works by modulating enteric nervous system 5, 6
  • GC-C agonists: For IBS-C
  • Antibiotics (e.g., rifaximin): For IBS with bloating 6, 3
  • Antidepressants: Particularly useful when psychological comorbidities exist 6

2. Dietary Modifications

  • Identify and avoid trigger foods
  • Consider dietary approaches (low FODMAP diet)
  • Ensure adequate fiber intake, particularly for IBS-C 1

3. Psychological Therapies

  • Cognitive behavioral therapy
  • Stress management techniques
  • Relaxation training 1, 6

Impact on Quality of Life

IBS significantly impacts quality of life:

  • Impairs physical, emotional, and social functioning
  • Causes work absenteeism
  • Creates substantial healthcare costs
  • Often associated with anxiety and depression 1

Prognosis

  • Chronic condition with waxing and waning symptoms
  • Poor prognostic factors include:
    • Long history of symptoms
    • Ongoing life stressors
    • Psychological comorbidities 1
  • Not associated with development of serious disease or excess mortality

IBS requires long-term management strategies focusing on symptom control and improving quality of life rather than cure.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.